Ascletis Pharma Inc
HKEX:1672

Watchlist Manager
Ascletis Pharma Inc Logo
Ascletis Pharma Inc
HKEX:1672
Watchlist
Price: 1.77 HKD -3.8% Market Closed
Market Cap: 1.7B HKD
Have any thoughts about
Ascletis Pharma Inc?
Write Note

Ascletis Pharma Inc
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascletis Pharma Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Ascletis Pharma Inc
HKEX:1672
Non-Reccuring Items
ÂĄ60.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Non-Reccuring Items
-ÂĄ248k
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Non-Reccuring Items
-ÂĄ222.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Non-Reccuring Items
-ÂĄ1.2m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Non-Reccuring Items
-ÂĄ1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Non-Reccuring Items
-ÂĄ106.9k
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ascletis Pharma Inc
Glance View

Market Cap
1.8B HKD
Industry
Biotechnology

Ascletis Pharma, Inc. operates as biotechnology firm to test the waters. The company is headquartered in Hangzhou, Zhejiang and currently employs 266 full-time employees. The company went IPO on 2018-08-01. The firm is focused on three therapeutic areas, including anti-viral, cancer and fatty liver disease. The Company’s main products include drugs against hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

Intrinsic Value
0.71 HKD
Overvaluation 60%
Intrinsic Value
Price

See Also

What is Ascletis Pharma Inc's Non-Reccuring Items?
Non-Reccuring Items
60.6m CNY

Based on the financial report for Dec 31, 2023, Ascletis Pharma Inc's Non-Reccuring Items amounts to 60.6m CNY.

Back to Top